Oaktree Life Sciences Lending Fund (Parallel 2), L.P. — Form D
Oaktree Life Sciences Lending Fund (Parallel 2), L.P. of LOS ANGELES, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-09-03. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-09-03
- Form: D
- Accession: 0001879383-21-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-412285
Issuer
- Name: Oaktree Life Sciences Lending Fund (Parallel 2), L.P.
- CIK: 0001879383
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2021
- Address: 333 S. GRAND AVENUE, LOS ANGELES, CA, 90071
- Phone: 213-830-6300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Howard Marks | Executive Officer | Beverly Hills, CA |
| Sheldon Stone | Executive Officer | Los Angeles, CA |
| Bruce Karsh | Executive Officer | Los Angeles, CA |
| Todd Molz | Executive Officer | Los Angeles, CA |
| Daniel Levin | Executive Officer | Los Angeles, CA |
| John Frank | Executive Officer | Los Angeles, CA |
| N/A Oaktree Capital Management, L.P. | Promoter | Los Angeles, CA |
| Jay Wintrob | Executive Officer | Los Angeles, CA |
| n/a Oaktree Life Sciences Lending Fund GP, L.P. | Executive Officer | Los Angeles, CA |
Other filings by this issuer (1)
More